Share This

Public company info - Livzon Pharmaceutical Group Inc. - H Shares , 01513.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

Livzon Pharmaceutical Group Inc. - H Shares, 01513.HK - Cash Flow 2022-12 2021-12 2020-12 2019-12 2018-12 2017-12 2016-12 2015-12 2014-12 2013-12 2012-12
Net Cash Flow from Operating Activities 3,797,501 3,138,029 3,227,018 2,778,389 2,999,196 1,315,865 1,279,215 927,788 1,452,338 1,059,681 1,096,748
Net Cash Flow from Return on Investments & Servicing of Finance -1,591,070 -1,501,348 -1,181,793 -1,054,758 -1,277,489 -265,263 -275,248 -105,960 -216,434 -192,257 -176,565
　Interest Received 0 0 0 0 0 0 0 0 0 0 40,137
　Interest Paid 0 0 0 0 0 0 0 0 0 0 0
　Dividend Received 0 0 0 0 0 0 0 0 0 0 0
　Dividend Paid -1,591,070 -1,501,348 -1,181,793 -1,054,758 -1,277,489 -265,263 -275,248 -105,960 -216,434 -192,257 -216,702
　Others 0 0 0 0 0 0 0 0 0 0 0
Taxes (Paid) / Refunded -1,024,829 -1,235,701 -1,066,257 -1,011,226 -1,731,575 0 0 0 -734,944 -619,694 -542,921
Net Cash Flow from Investing Activities -1,229,870 -1,876,900 -467,844 -316,024 -1,020,845 4,672,721 -943,242 -558,420 -738,006 -874,565 -895,490
　Additions to Fixed Assets -940,146 -1,309,102 -646,976 -397,997 -474,472 -294,152 -368,459 -477,134 -665,519 -920,001 -762,302
　Disposal of Fixed Assets 2,959 9,088 5,115 1,859 450 2,537 4,041 6,996 2,830 186 341
　Increase in Investments -399,184 -786,000 -129,187 -126,120 -609,804 -188,718 -672,575 -80,832 -93,255 -460 -151,533
　Decrease in Investments 130,686 211,996 278,621 136,142 62,981 4,479,932 93,751 478 10,182 46,532 16,855
　Net Cash Flow with Related Parties 42,246 798,267 357,265 11,702 0 15,000 0 298,883 98,000 51,500 0
　Others -66,431 -801,149 -332,682 58,390 0 658,122 0 -306,811 -90,244 -52,322 1,149
Net Cash Flow before Financing Activities -48,268 -1,475,920 511,124 396,380 -1,030,713 5,723,323 60,725 263,408 -237,046 -626,836 -518,228
Net Cash Flow from Financing Activities 870,714 686,330 663,751 -126,324 2,134,913 -317,870 1,214,013 -208,923 195,552 200,023 263,907
　New Loans 3,713,517 2,799,881 2,383,580 1,509,317 1,800,000 0 860,000 736,000 964,948 947,018 502,258
　Loans Repayment -2,804,798 -2,033,581 -1,829,811 -1,650,000 -300,000 -350,000 -1,510,000 -1,242,009 -1,167,397 -1,235,161 -620,751
　Fixed Income/Debt Instruments 0 0 0 0 0 0 350,000 0 300,000 400,000 400,000
　Repayment of Fixed Income/Debt Instruments 0 0 0 0 0 0 0 0 0 0 0
　Equity Financing 0 0 0 0 0 0 0 0 0 0 0
　Net Cash Flow with Related Parties 42,246 798,267 357,265 11,702 0 15,000 0 298,883 98,000 51,500 0
　Others -80,251 -878,237 -247,283 2,657 634,913 17,130 1,514,013 -1,797 1 36,666 -17,600
Increase(Decrease) in Cash & Cash Equivalents 822,446 -789,590 1,174,874 270,057 1,104,200 5,405,453 1,274,737 54,485 -41,494 -426,812 -254,320
Cash & Cash Equivalents at Beginning of Year 9,125,310 9,952,050 8,854,186 8,563,711 7,400,974 2,061,923 767,093 709,114 750,929 1,178,636 1,432,176
Net Cash Flow due to Change in Exchange Rate/Others 124,887 -37,150 -77,010 20,418 58,537 -66,402 20,092 3,494 -320 -895 781
Cash & Cash Equivalents at End of Year 10,072,643 9,125,310 9,952,050 8,854,186 8,563,711 7,400,974 2,061,923 767,093 709,114 750,929 1,178,636
Currency Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi
Unit
Auditor's Opinion 1 1 1 1 1 1 1 1 1 1 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.